title: Editorial (Thematic Issue: Clinical Advances in Immuno-oncology - Progress Towards Selective Cure).
authors.affiliation: Clinical Research Project Manager Penn State Hershey Cancer Institute Clinical Trial Office Room T3401 500 University Drive CH56 PO Box 850 Hershey, PA 17033-0850. xliu2@hmc.psu.edu.
authors.forename: Xin
authors.initials: X
authors.lastname: Liu
authors.affiliation: Miriam Beckner Distinguished Professor of Medicine Penn State College of Medicine Deputy Director, Penn State Hershey Cancer Institute Penn State Milton S. Hershey Medical Center 500 University Drive, CH72 Hershey, PA 17033. cbelani@psu.edu.
authors.forename: Chandra P
authors.initials: CP
authors.lastname: Belani
mesh_terms: D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use*; D004059:Diffusion of Innovation; D055808:Drug Discovery / Q000639:trends; D006801:Humans; D007167:Immunotherapy / Q000639:trends*; D008495:Medical Oncology / Q000639:trends*; D058990:Molecular Targeted Therapy / Q000639:trends; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality / Q000473:pathology
chemical_list: D000074322:Antineoplastic Agents, Immunological